Jordan Paradise

Co-Chair, Beazley Institute for Health Law and Policy

Mifepristone Paternalism at the FDA, 51 J. L. MED. & ETHICS 554 (2023)

Stumbling Over TRIPS: The International Intellectual Property Waiver Petition and the U.S. Executive, 30 MICH. ST. INT’l L. REV. 249 (2022) (with Conroy)

Information Opacity in Biopharmaceutical Innovation Through the Lens of COVID-19, 47 AM. J. L. & MED. 157 (2021)

Insulin Federalism, 27 B.U. J. SCI & TECH. L. 118 (2021)

Pandemic Politics, Public Health, and the FDA, 8 BELMONT L. REV. 301 (2021) (with Bavlsik)

Mifepristone Paternalism at the FDA, 51 J. L. MED. & ETHICS 554 (2023)

Stumbling Over TRIPS: The International Intellectual Property Waiver Petition and the U.S. Executive, 30 MICH. ST. INT’l L. REV. 249 (2022) (with Conroy)

Information Opacity in Biopharmaceutical Innovation Through the Lens of COVID-19, 47 AM. J. L. & MED. 157 (2021)

Insulin Federalism, 27 B.U. J. SCI & TECH. L. 118 (2021)

Pandemic Politics, Public Health, and the FDA, 8 BELMONT L. REV. 301 (2021) (with Bavlsik)